IQVIA Holdings Inc (IQV) Actualités

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

IQVIA Reports Second-Quarter 2024 Results

Revenue of $3,814 million GAAP Net Income of $363 million, Adjusted EBITDA of $887 million GAAP Diluted Earnings per Share of $1.97, Adjusted...

IQVIA Named a Leader in Medical Affairs and Regulatory Operations by Everest Group

IQVIA™ (NYSE:IQV) today announces that a leading, independent research firm, Everest Group, has recognized IQVIA as a Leader in its Life Sciences...

IQVIA to Announce Second-Quarter 2024 Results on July 22, 2024

IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) will announce its second-quarter 2024 financial results before the market opens on Monday, July 22...

IQVIA’s SmartSolve® eQMS Wins 2024 MedTech Breakthrough Award “Best Use of Artificial Intelligence in Healthcare”

IQVIA™ (NYSE:IQV), a leading global provider of AI-powered analytics, technology solutions, and clinical research services to the life sciences...

IQVIA Launches “One Home” Clinical Trial Technology Platform – Solves Challenges and Reduces Overload at Sites

Bold initiative to boost the capacity of research sites enters Beta testing and piloting IQVIA (NYSE:IQV) today announced the launch of One Home...

IQVIA Institute: Innovative Therapies and Strong Pipeline to Combat Rise in Cancer Diagnoses

Cancer incidence is expected to rise significantly through 2050, particularly in lower-income countries, to 32 million new cases annually – a...

Form 3 - Initial statement of beneficial ownership of securities

U.S. Medicines Spending Grew in 2023 as Greater Access Offset COVID-19-related Decline, Says IQVIA Institute

Overall spending in the U.S. market for medicines grew 2.5% in 2023, reaching $435Bn at net price level, reflecting a sharp decline in COVID-19...

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities